当前位置：首页 > 文献互助 > 互助详情

Suzetrigine: First Approval复制

用户1EPy-xGJnvBY 4个月前 126 10 已完结

1. 系统已在2025-06-11 15:35:14对应助文件进行删除

2. 如有需要请重新发布求助信息

注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规

DOI:复制

文献链接:复制

其他信息:

SJ Keam
Drugs, 2025
Springer
… On 30 January 2025, suzetrigine was approved for the … Suzetrigine is the first NaV inhibitor to be approved in this new … development of suzetrigine leading to this first approval for the …

上一篇： Suzetrigine: The Newest Hammer for Postoperative Pain Whack-a-Mole

下一篇：US Food and Drug Administration Approval of Suzetrigine: A Breakthrough in Nonopioid Pain Management

互助时间线

2025-06-04 17:00:06 [完结求助]

楼主确认了jodie0105应助的文件是正确的, 求助状态变成 已完结

2025-06-04 15:35:14 [上传文件]

jodie0105上传了文件(zip 1011.74 KB), 求助状态变成 待确认

2025-06-04 09:09:14 [发起求助]

最新发布的求助

Development of Dual FLT3 and CHK1 PROTACs for the Treatment of AML 2分钟前
What Is the Rate-Limiting Step of Oxygen Reduction Reaction on Fe–N–C Catalysts? 2小时前
MDM2 Degrader as a Promising Therapeutic Strategy for Cancer Treatment 2小时前
Synthetic methods for high-entropy nanomaterials 4小时前
Understanding the role of short- and long-range intermolecular interactions in novel computational drug discovery 5小时前
Synthesis of Novel SRPK1-Targeting Hybrid Compounds Incorporating Antimetabolites for Cancer Therapy 5小时前
Discovery of a First-in-Class SLIT2 Binder Disrupting the SLIT2/ROBO1 Axis via DNA-Encoded Library (DEL) Screening 5小时前
Topoisomerase II inhibitors in oncology: an updated patent review (2016-present) 5小时前
Toll-like receptor agonists as cancer therapeutics: a patent review (2014–2024) 5小时前
A patent review of MLKL modulators (2023 – present) 5小时前
The effect of high tibial osteotomy on osteoarthritis of the knee. An arthroscopic study of 54 knee joints 6小时前
Effects of a contusion load on spinal cord with different curvatures 7小时前

wispass工作室 Copyright © 蜀ICP备2024051606号-2 www.wispass.com